ArticleScientific reports2022

Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer.

Ye Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.